Cbio A/S

📍 Søborg, Denmark🗓 Founded 2019👥 13 employees💰 Last funded Feb 2024
Biotechnology Research🌐 cbio.dk
Website LinkedIn
Cbio A/S is a biopharmaceutical company developing next generation T-cell therapies against solid tumors. We are soon to enter our First-in-Human clinical study at Karolinska Hospital in Sweden with our proprietary T-cell product, novoleucel, where the T-cell are armed against oxidative stress. We are located in Copenhagen, Denmark in a 1,000 m2 state-of-the-art facility where we develop and produce cell-based therapy products for clinical use.
3
Total investors
2
Early stage
1
Mid stage
0
Late stage
2019
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Denmark
3
Investor activity2020–2024 · investors recorded per year
2020220241
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Cbio A/S?
Cbio A/S has 3 investors on record on gritt.io, including 2 early-stage backers, 1 mid-stage.
When did Cbio A/S last raise funding?
The most recent investment in Cbio A/S recorded on gritt.io was in February 2024.
When was Cbio A/S founded?
Cbio A/S was founded in 2019.
What industry is Cbio A/S in?
Cbio A/S operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Cbio A/S based?
Cbio A/S is headquartered in Søborg, Denmark.